1st Circ. Affirms $26M Award In Sulindac Injury Suit
The First Circuit on Wednesday affirmed a $26 million award given to a woman who suffered a near-fatal reaction after taking Mutual Pharmaceutical Co. Inc.'s generic drug Sulindac, ruling that design...To view the full article, register now.
Already a subscriber? Click here to view full article